Chemotherapy Target in Elderly’s West African
Patient. West African Elderly’s Patients: Results of
Using Tyrosine Kinase Inhibitors (Niger).

Fahri Ozsungur

Short Communication

Chemotherapy Target in Elderly’s West African Patient. West African Elderly’s Patients: Results of Using Tyrosine Kinase Inhibitors (Niger).

Andia A¹*, Amadou D², Amadou HR¹, Maiga Z³, Agali ZR¹, S Sarah¹, Garba KK¹, Ibrahim F¹, Saidou R¹, Laurent Y¹, Brah S¹, Malam AB², Adehossi E¹

¹Department of Internal medicine and geriatric in Niamey’s Reference hospital.

²Department of Onco-Haematoly Niamey’s National hospital.

³Department of General medicine in Maradi Reference’s hospital.

Corresponding Author

Received Date: February 04, 2021 Published Date: March 02, 2021

Abstract

The Chronic Myeloid Leukemia is caused by the BCR-ABL gene formation encoding aberrant oncoprotein tyrosine kinase. The Tyrosine Kinase Inhibitors (TKIs) induces durable deep molecular response, so elderly patient had concerned probably due to demography and epidemiological transition even if myelodysplasia syndrom is the most frequent homeopathy in elderly person. The review of literature about chemotherapy in elderly is rare and the studies found a comparable result as same as in adult [1]. The G8 oncodage tools is recommended by the international society of Oncogeriatry to screening the geriatric syndroms and should be completed by multi-dimensional geriatric assessment when the G8 score is inferior or egal to 14 [1].

Article Details

Citation

Andia A, Amadou D, Amadou HR, Maiga Z, Agali ZR. Chemotherapy Target in Elderly’s West African Patient. West African Elderly’s Patients: Results of Using Tyrosine Kinase Inhibitors (Niger). Glob J Aging Geriatr Res. 1(3): 2021. GJAGR.MS.ID.000513.